These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32233274)

  • 21. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiences with novel techniques for reduction of stent flow in transjugular intrahepatic portosystemic shunts.
    Gerbes AL; Waggershauser T; Holl J; Gülberg V; Fischer G; Reiser M
    Z Gastroenterol; 1998 May; 36(5):373-7. PubMed ID: 9654704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.
    Sanyal AJ; Freedman AM; Shiffman ML; Purdum PP; Luketic VA; Cheatham AK
    Hepatology; 1994 Jul; 20(1 Pt 1):46-55. PubMed ID: 8020904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transjugular intrahepatic portosystemic shunts: an update.
    Rosado B; Kamath PS
    Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research advances in diagnosis and treatment of post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy].
    Yang JF; Zhang BQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):545-548. PubMed ID: 27784438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].
    Martínez Moreno B; Bellot P; de España F; Palazón JM; Such J; Pérez-Mateo M
    Gastroenterol Hepatol; 2011; 34(7):468-73. PubMed ID: 21652116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Philips CA; Rajesh S; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2020 Aug; 39(4):377-387. PubMed ID: 32929684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Trivedi S; Lam K; Ganesh A; Hasnain Y; Hassan W; Herren J; Gaba RC
    Semin Intervent Radiol; 2023 Feb; 40(1):9-14. PubMed ID: 37152788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant hepatic encephalopathy and refractory ascites: successful treatment with staged embolization of two large portosystemic shunts and transjugular intrahepatic portosystemic shunt placement.
    Smith JC; Black MD; Mendler MH
    J Vasc Interv Radiol; 2007 Nov; 18(11):1441-6. PubMed ID: 18003997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): casting a retrospective glance and future perspectives].
    Schultheiß M; Bettinger D; Thimme R; Rössle M
    Z Gastroenterol; 2020 Sep; 58(9):877-889. PubMed ID: 32947633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.